Expand to Europe
Transcending traditional full
outsourcing or licensing agreements.
Expanding to EU is a complex challenge that requires local presence, regional and country-specific expertise, internal resource allocation, and local hiring for roles that may not need full-time positions from the onset.
This may potentially divert crucial focus, effort, and resources from the US product launch.
Biopharmaceutical companies are seeking solutions to enter the EU market, while retaining control over their assets, unlike traditional licensing agreements.
These solutions must provide time and cost efficiency, establish a strong foundation for self-directed commercialization, adhere to strict local regulatory requirements, and provide flexibility in hiring.
Expand to Europe
A unique partnership model.
We offer a strategic joint venture model that ensures a seamless market extension to Europe for US Biopharmaceutical companies.
This partnership leverages our regional and local expertise and ensures aligned interests and shared success.
We manage every aspect efficiently, minimizing costs to maximize joint venture benefits.
This approach not only navigates the complex European market effectively but also strategically positions our partners for financial and operational success.
In summary, we offer :
- Formation of a dedicated Joint Venture, with AzurBio Pharma managing daily EU operations supported by the biotech’s financial backing.
- A single point of contact for comprehensive regional and local expertise in regulatory affairs, medical strategy, market access, and commercial operations, enhancing focus and efficiency.